Notably, the high GSH metabolism group exhibited lower immune scores and CD8+ T cell proportions compared to the low-metabolism group, suggesting that glutathione metabolism may regulate anti-tumor immune responses by influencing T cell differentiation and functional states. Here, CD8A is linked to neoplasm.